{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:54:03Z","timestamp":1790985243683,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,30]]},"DOI":"10.7759\/cureus.74834","type":"journal-article","created":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T14:59:32Z","timestamp":1732978772000},"source":"Crossref","is-referenced-by-count":1,"title":["Peritoneal Dissemination and Malignant Ascites in Duodenal Cancer Successfully Treated With Adoptive Cell Therapy Using WT1- and MUC1-Pulsed Dendritic Cells and Activated T Cells With No Adverse Effects: A Case Report"],"prefix":"10.7759","author":[{"given":"Yohsuke","family":"Yagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunobu","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izumi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Koido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruo","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keishi","family":"Tanigawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-018-6567-6","article-title":"Outcomes and treatment options for duodenal adenocarcinoma: a systematic review and meta-analysis","volume":"25","author":"Meijer LL","year":"2018","unstructured":"Meijer LL, Alberga AJ, de Bakker JK, et al.. Outcomes and treatment options for duodenal adenocarcinoma: a systematic review and meta-analysis. Ann Surg Oncol. 2018, 25:2681-92. 10.1245\/s10434-018-6567-6","journal-title":"Ann Surg Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198001000-00003","article-title":"Primary carcinoma of the duodenum","volume":"191","author":"Alwmark A","year":"1980","unstructured":"Alwmark A, Andersson A, Lasson A. Primary carcinoma of the duodenum. Ann Surg. 1980, 191:13-8. 10.1097\/00000658-198001000-00003","journal-title":"Ann Surg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-021-01841-9","article-title":"Surgical results of non-ampullary duodenal cancer: a nationwide survey in Japan","volume":"57","author":"Nakagawa K","year":"2022","unstructured":"Nakagawa K, Sho M, Okada KI, et al.. Surgical results of non-ampullary duodenal cancer: a nationwide survey in Japan. J Gastroenterol. 2022, 57:70-81. 10.1007\/s00535-021-01841-9","journal-title":"J Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-022-01919-y","article-title":"Clinical practice guidelines for duodenal cancer 2021","volume":"57","author":"Nakagawa K","year":"2022","unstructured":"Nakagawa K, Sho M, Fujishiro M, et al.. Clinical practice guidelines for duodenal cancer 2021. J Gastroenterol. 2022, 57:927-41. 10.1007\/s00535-022-01919-y","journal-title":"J Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-100311-102839","article-title":"Decisions about dendritic cells: past, present, and future","volume":"30","author":"Steinman RM","year":"2012","unstructured":"Steinman RM. Decisions about dendritic cells: past, present, and future. Annu Rev Immunol. 2012, 30:1-22. 10.1146\/annurev-immunol-100311-102839","journal-title":"Annu Rev Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-008-0568-4","article-title":"Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters","volume":"58","author":"Engell-Noerregaard L","year":"2009","unstructured":"Engell-Noerregaard L, Hansen TH, Andersen MH, Thor Straten P, Svane IM. Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters. Cancer Immunol Immunother. 2009, 58:1-14. 10.1007\/s00262-008-0568-4","journal-title":"Cancer Immunol Immunother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/nm1104-1153a","article-title":"Translation of cancer immunotherapies","volume":"10","author":"Mul\u00e9 JJ","year":"2004","unstructured":"Mul\u00e9 JJ, Weber JS. Translation of cancer immunotherapies. Nat Med. 2004, 10:1153; author reply 1153-4. 10.1038\/nm1104-1153a","journal-title":"Nat Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0737","article-title":"The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research","volume":"15","author":"Cheever MA","year":"2009","unstructured":"Cheever MA, Allison JP, Ferris AS, et al.. The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research. Clin Cancer Res. 2009, 15:5323-37. 10.1158\/1078-0432.CCR-09-0737","journal-title":"Clin Cancer Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-024-04363-z","article-title":"Dendritic cell vaccination in combination with erlotinib in a patient with inoperable lung adenocarcinoma: a case report","volume":"18","author":"Kosumi T","year":"2024","unstructured":"Kosumi T, Kobayashi M, Shimodaira S, Sugiyama H, Koido S. Dendritic cell vaccination in combination with erlotinib in a patient with inoperable lung adenocarcinoma: a case report. J Med Case Rep. 2024, 18:88. 10.1186\/s13256-024-04363-z","journal-title":"J Med Case Rep"},{"key":"ref10","article-title":"A phase I trial of tumor lysate-pulsed dendritic cells in the treatment of advanced cancer","volume":"8","author":"Chang AE","year":"2002","unstructured":"Chang AE, Redman BG, Whitfield JR, et al.. A phase I trial of tumor lysate-pulsed dendritic cells in the treatment of advanced cancer. Clin Cancer Res. 2002, 8:1021-32.","journal-title":"Clin Cancer Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines3041004","article-title":"Dendritic cell-based adjuvant vaccination targeting Wilms\u2019 tumor 1 in patients with advanced colorectal cancer","volume":"3","author":"Shimodaira S","year":"2015","unstructured":"Shimodaira S, Sano K, Hirabayashi K, et al.. Dendritic cell-based adjuvant vaccination targeting Wilms\u2019 tumor 1 in patients with advanced colorectal cancer. Vaccines (Basel). 2015, 3:1004-18. 10.3390\/vaccines3041004","journal-title":"Vaccines (Basel)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.2.796","article-title":"Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2","volume":"15","author":"Chang AE","year":"1997","unstructured":"Chang AE, Aruga A, Cameron MJ, Sondak VK, Normolle DP, Fox BA, Shu S. Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2. J Clin Oncol. 1997, 15:796-807. 10.1200\/JCO.1997.15.2.796","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.18103\/mra.v10i4.2762","article-title":"WT1 cancer vaccine for the treatment and prevention","volume":"10","author":"Sugiyama H","year":"2022","unstructured":"Sugiyama H. WT1 cancer vaccine for the treatment and prevention. Med Res Arch. 2022, 10:1-45. 10.18103\/mra.v10i4.2762","journal-title":"Med Res Arch"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.12.4.493","article-title":"Dendritic cell vaccine immunotherapy of cancer targeting MUC1 mucin","volume":"12","author":"Kontani K","year":"2003","unstructured":"Kontani K, Taguchi O, Ozaki Y, et al.. Dendritic cell vaccine immunotherapy of cancer targeting MUC1 mucin. Int J Mol Med. 2003, 12:493-502. 10.3892\/ijmm.12.4.493","journal-title":"Int J Mol Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00534-011-0437-y","article-title":"Clinical utilization of postoperative dendritic cell vaccine plus activated T-cell transfer in patients with intrahepatic cholangiocarcinoma","volume":"19","author":"Shimizu K","year":"2012","unstructured":"Shimizu K, Kotera Y, Aruga A, Takeshita N, Takasaki K, Yamamoto M. Clinical utilization of postoperative dendritic cell vaccine plus activated T-cell transfer in patients with intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2012, 19:171-8. 10.1007\/s00534-011-0437-y","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2020.5110","article-title":"Impact of mature dendritic cells pulsed with a novel WT1 helper peptide on the induction of HLA\u2011A2\u2011restricted WT1\u2011reactive CD8+ T cells","volume":"57","author":"Kan S","year":"2020","unstructured":"Kan S, Bito T, Shimabuku M, et al.. Impact of mature dendritic cells pulsed with a novel WT1 helper peptide on the induction of HLA\u2011A2\u2011restricted WT1\u2011reactive CD8+ T cells. Int J Oncol. 2020, 57:1047-56. 10.3892\/ijo.2020.5110","journal-title":"Int J Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02654-4","article-title":"Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial","volume":"356","author":"Takayama T","year":"2000","unstructured":"Takayama T, Sekine T, Makuuchi M, et al.. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet. 2000, 356:802-7. 10.1016\/S0140-6736(00)02654-4","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/0753-3322(93)90294-U","article-title":"A feasible method for expansion of peripheral blood lymphocytes by culture with immobilized anti-CD3 monoclonal antibody and interleukin-2 for use in adoptive immunotherapy of cancer patients","volume":"47","author":"Sekine T","year":"1993","unstructured":"Sekine T, Shiraiwa H, Yamazaki T, et al.. A feasible method for expansion of peripheral blood lymphocytes by culture with immobilized anti-CD3 monoclonal antibody and interleukin-2 for use in adoptive immunotherapy of cancer patients. Biomed Pharmacother. 1993, 47:73-8. 10.1016\/0753-3322(93)90294-U","journal-title":"Biomed Pharmacother"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2015.04.004","article-title":"The incidence and prognosis of true duodenal carcinomas","volume":"24","author":"Buchbjerg T","year":"2015","unstructured":"Buchbjerg T, Fristrup C, Mortensen MB. The incidence and prognosis of true duodenal carcinomas. Surg Oncol. 2015, 24:110-6. 10.1016\/j.suronc.2015.04.004","journal-title":"Surg Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-6572-6","article-title":"Bidirectional treatment of peritoneal metastasis with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) and systemic chemotherapy: a systematic review","volume":"20","author":"Ploug M","year":"2020","unstructured":"Ploug M, Graversen M, Pfeiffer P, Mortensen MB. Bidirectional treatment of peritoneal metastasis with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) and systemic chemotherapy: a systematic review. BMC Cancer. 2020, 20:105. 10.1186\/s12885-020-6572-6","journal-title":"BMC Cancer"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2016-0031","article-title":"Wilms' tumor 1 (WT1)-targeted cancer vaccines to extend survival for patients with pancreatic cancer","volume":"8","author":"Koido S","year":"2016","unstructured":"Koido S, Okamoto M, Shimodaira S, Sugiyama H. Wilms' tumor 1 (WT1)-targeted cancer vaccines to extend survival for patients with pancreatic cancer. Immunotherapy. 2016, 8:1309-20. 10.2217\/imt-2016-0031","journal-title":"Immunotherapy"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(88)90088-0","article-title":"High molecular weight epithelial mucins as markers in breast cancer","volume":"24","author":"Price MR","year":"1988","unstructured":"Price MR. High molecular weight epithelial mucins as markers in breast cancer. Eur J Cancer Clin Oncol. 1988, 24:1799-804. 10.1016\/0277-5379(88)90088-0","journal-title":"Eur J Cancer Clin Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26338","article-title":"Extremely strong infiltration of WT1-specific CTLs into mouse tumor by the combination vaccine with WT1-specific CTL and helper peptides","volume":"9","author":"Nakata J","year":"2018","unstructured":"Nakata J, Nakajima H, Hayashibara H, et al.. Extremely strong infiltration of WT1-specific CTLs into mouse tumor by the combination vaccine with WT1-specific CTL and helper peptides. Oncotarget. 2018, 9:36029-38. 10.18632\/oncotarget.26338","journal-title":"Oncotarget"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2183\/pjab.91.292","article-title":"Discovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapy","volume":"91","author":"Taniguchi M","year":"2015","unstructured":"Taniguchi M, Harada M, Dashtsoodol N, Kojo S. Discovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapy. Proc Jpn Acad Ser B Phys Biol Sci. 2015, 91:292-304. 10.2183\/pjab.91.292","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03221-2","article-title":"Detection of immunogenic cell death and its relevance for cancer therapy","volume":"11","author":"Fucikova J","year":"2020","unstructured":"Fucikova J, Kepp O, Kasikova L, et al.. Detection of immunogenic cell death and its relevance for cancer therapy. Cell Death Dis. 2020, 11:1013. 10.1038\/s41419-020-03221-2","journal-title":"Cell Death Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2355","article-title":"Adoptive cell transfer: a clinical path to effective cancer immunotherapy","volume":"8","author":"Rosenberg SA","year":"2008","unstructured":"Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME. Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer. 2008, 8:299-308. 10.1038\/nrc2355","journal-title":"Nat Rev Cancer"},{"key":"ref27","article-title":"The current and future applications of immunopharmacogenomics","volume":"13","author":"Nakamura Y","year":"2015","unstructured":"Nakamura Y. The current and future applications of immunopharmacogenomics. Clin Adv Hematol Oncol. 2015, 13:815-7.","journal-title":"Clin Adv Hematol Oncol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1126\/science.274.5284.94","article-title":"Phenotypic analysis of antigen-specific T lymphocytes","volume":"274","author":"Altman JD","year":"1996","unstructured":"Altman JD, Moss PA, Goulder PJ, et al.. Phenotypic analysis of antigen-specific T lymphocytes. Science. 1996, 274:94-6. 10.1126\/science.274.5284.94","journal-title":"Science"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/308954-peritoneal-dissemination-and-malignant-ascites-in-duodenal-cancer-successfully-treated-with-adoptive-cell-therapy-using-wt1--and-muc1-pulsed-dendritic-cells-and-activated-t-cells-with-no-adverse-effects-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T14:59:34Z","timestamp":1732978774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/308954-peritoneal-dissemination-and-malignant-ascites-in-duodenal-cancer-successfully-treated-with-adoptive-cell-therapy-using-wt1--and-muc1-pulsed-dendritic-cells-and-activated-t-cells-with-no-adverse-effects-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,30]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.74834","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,30]]}}}